. However, the mechanism by which remodellers discriminate between different nucleosome substrates is poorly understood. Many chromatin remodelling proteins possess conserved protein domains that interact with nucleosomal features 2 . Here we used a quantitative high-throughput approach, based on the use of a DNA-barcoded mononucleosome library, to profile the biochemical activity of human ISWI family remodellers in response to a diverse set of nucleosome modifications. We show that accessory (non-ATPase) subunits of ISWI remodellers can distinguish between differentially modified nucleosomes, directing remodelling activity towards specific nucleosome substrates according to their modification state. Unexpectedly, we show that the nucleosome acidic patch 3 is necessary for maximum activity of all ISWI remodellers evaluated. This dependence also extends to CHD and SWI/SNF family remodellers, suggesting that the acidic patch may be generally required for chromatin remodelling. Critically, remodelling activity can be regulated by modifications neighbouring the acidic patch, signifying that it may act as a tunable interaction hotspot for ATPdependent chromatin remodellers and, by extension, many other chromatin effectors that engage this region of the nucleosome surface 4-9
Diagram depicting all histone modifications, mutants, and variants present in the 115member nucleosome library used in this study. Residues modified or mutated were mapped on to the nucleosome (PDB: 1KX5) in black using UCSF Chimera. H2A (light yellow), H2B (light red), H3 (light blue) and H4 (light green) modification and mutation locations are indicated by boxes and lines. For clarity, connections are shown to only a single copy of each histone protein.
Letter reSeArCH DNA, histones, and histone posttranslational modifications (PTMs) 2 , providing the potential for these domains to act as a means to interpret unique chromatin landscapes by modulating binding to nucleosomes or the DNA translocation efficiency of the ATPase. Though these effects have long been proposed, only a small number of studies have described how modifications to nucleosomes, which occur in massive complexity in vivo 10 , affect remodelling efficacy [11] [12] [13] [14] [15] [16] [17] . To our knowledge, there has been no systematic analysis of how remodelling activity is tuned by the presence of nucleosome modifications.
Recently, we described an approach for accelerated biochemical analysis of chromatin effectors based on the use of DNAbarcoded mon onucleosome libraries 18 . An expanded version of this library ( Table 1 ) encompassed a broad range of modifications distributed throughout the nucleosome structure and was specifically tailored for studying chromatin remodelling using a modified restriction enzyme accessibility assay 19 (Fig. 2a) . We used this library to profile the remod elling behaviour (that is, nucleosome sliding) of seven recombinantly produced human ISWI remodellers; namely the SNF2h ATPase and the ACF, CHRAC, WICH, NoRC, RSF and NURF complexes (Extended Data Fig. 3 ). In total, this effort generated 784 remodelling rate constants from 28,224 individual kinetic measurements ( Table 3 ). In addition, and consistent with previous work, nucleosomes containing modifications or mutations in the basic patch of the H4 tail were poor substrates of ISWI remodellers 15, 20 , whereas nucleosomes containing the histone variant H2A.Z led to enhanced remodelling activity 17 (Fig. 2e) . Finally, restriction enzyme cleavage of a DNA standard present in the library that is unoccupied by a histone octamer (DNA Standard 2) was always Letter reSeArCH faster than nucleosome remodelling, ensuring its activity was not limiting in our assay. Inspection of the kinetic data revealed that ISWI remodellers are broadly sensitive to nucleosome modifications, with both stimulatory and inhibitory effects evident for all seven enzymes tested ( Fig. 2b and Supplementary Table 3 ). We performed principal component analysis (PCA) to identify experimental trends that contributed to variability in remodeller activity towards different nucleosome substrates. The first principal component accounted for the large majority of variance (83%) in the data (Extended Data Fig. 5a ). Notably, all remodellers had very similar weight values for PC1, demonstrating that histone modifications that stimulate or impede remodelling tend to do so similarly over all the enzymes tested. This suggests that remodellers share functional motifs (for example, in the common ATPase subunit) that are similarly sensitive to changes in the substrate structure, and/or that certain modifications affect the stability of the nucleosome to make DNA translocation more or less difficult ( Supplementary Fig. 3 ).
The second and third principal components revealed how the activity of the remodellers varies in response to specific nucleosome substrates (Fig. 3a) . Notably, PCA showed that the activity of the isolated SNF2h ATPase is distinct from all complexes that incorporate the ATPase for DNA translocation activity, indicating that bound accessory subunits repurpose remodelling activity in response to individual nucleosome modification states. Subsets of the nucleosome library drive differences in remodeller activity; the most prominent of these is the H3K14ac modification, which activates only the NoRC complex (Fig. 3b , Extended Data Fig. 5b, Supplementary Table 4) . Indeed, we found many individual cases in which a specific nucleosome type had a broad range of effects across different remodellers (Fig. 3b) , providing further evidence that the unique subunit compositions of each complex play a direct role in determining their functional specialization. We also observed that histone modifications located on more accessible regions of the nucleosome (for example, on the flexible tails) showed more variability in their effects across different remodellers than those residing under the DNA, which generally elicited similar behaviour across the remodellers evaluated, probably owing to their ability to alter histone-DNA contacts and affect the DNA translocation efficiency of the ATPase subunit 21 ( Fig. 3c and Extended Data Fig. 6a, b ). Further analysis of the remodelling dataset provided insights into the relationship between remodelling activity and the binding pref erences of histone recognition ('reader') domains within the ISWI remodellers. This was particularly enlightening for the NoRC, WICH, and NURF complexes, all of which have reader domains within their accessory subunits whose binding preferences have been studied [22] [23] [24] . In the case of the NoRC complex, the binding preferences of associ ated reader domains were an excellent predictor of remodelling output (Extended Data Fig. 7a ). This relationship was much less pronounced for the WICH complex (Extended Data Fig. 7b ) and, in the case of the NURF complex, we observed an inverse correlation between expected binding preferences and remodelling activity (Extended Data Figs 7c, 8a). In considering the origins of such behaviour, it is worth noting that binding studies on chromatin factors typically employ isolated reader domains and/or histonederived peptides 25, 26 . These simplified systems, while often informative, are not subject to the same structural and steric constraints as are present in a more physiological setting. Our data highlight the advantages of performing biochemical meas urements with intact chromatin effectors and nucleosomal substrates.
Unexpectedly, we found that a nucleosome in our library in which the socalled 'acidic patch' 3 had been disrupted through muta tion was inefficiently remodelled by all ISWI family remodellers Letter reSeArCH examined (Fig. 4a) . The nucleosome acidic patch is a unique surface feature created by a cluster of acidic residues within the core regions of histones H2A and H2B that together create a negatively charged cleft on each face of the nucleosome disc (Fig. 4a) . This surface epitope has emerged as an important component of chromatin recognition [4] [5] [6] [7] [8] [9] . Through further mutagenesis studies, we showed that ISWI remo delling activity requires a trio of amino acids in H2A (E61, D90 and E92) that are known to form a binding pocket for arginine residues within other transacting chromatin factors 27 (Fig. 4b , Extended Data Fig. 8b ). Further implicating this region, remodelling of unmodified nucleosomes by the ACF complex was inhibited by addition of the latencyassociated nuclear antigen (LANA) peptide from the Kaposi sarcomaassociated herpes virus, which is known to bind the acidic patch using the arginine anchor paradigm 8 (Extended Data Fig. 8c ). We also found that ATPases from the CHD family (CHD4) and SWI/SNF family (BRG1) of remodellers were sensitive to the acidic patch, suggesting that it may be generally required for chromatin remodelling (Fig. 4b) .
The number of proteins known to bind and utilize the acidic patch in their interactions with chromatin is continually rising 27 . It is thus intriguing to speculate that modifications in the neighbourhood of the acidic patch alter the binding of ligands, perhaps in a differential manner. For example, H2A.Z provides two additional residues that extend the acidic patch and enhance ISWI remodelling activity 17 . Other studies hint at this possibility as well 28 . Analysis of our dataset reveals that ISWI remodelling activity is affected by diverse histone PTMs located near the acidic patch (Fig. 4a) . Notably, both stimulation and inhibition of nucleosome sliding activity was observed in response to these PTMs (Fig. 4a, Extended Data Fig. 8d ). The activity profile of each remodeller was similar across this substrate set, suggesting that a common sensing mechanism was operational across the ISWI remodeller family. We anticipate that such a mechanism is mediated by the ATPase subunit, as it is the only shared component of the complexes. Consistent with this assignment, the isolated SNF2h ATPase subunit was also found to require an intact acidic patch for activity (Fig. 4a) . We imagine that the acidic patch may act by stabilizing a SNF2h-nucleosome interaction, or, in considering known modes of ISWI regulation by nucleosomal epitopes 29 , we can also envision possible allosteric mechanisms.
On the basis of the above findings, we used our nucleosome library platform to investigate the possibility that certain PTMs or histone variants may act as 'selectivity filters' for the acidic patch, granting access to subsets of chromatin effectors. In addition to ISWI remodellers, we observed this to be the case for CHD4, RCC1, and Sir3, all factors that we demonstrate, or have previously been demonstrated 5, 6 , to engage the acidic patch (Fig. 4c, Extended Data Fig. 9 , Supplementary 
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and Supplementary Table 7) . We note that compared to PTMs within histone Nterminal tails, which have been extensively studied with respect to chromatin regulation, those residing within the core of the histone octamer are much more enigmatic 21 . We imagine that the acidic patch is able to act as a compositionally dynamic and regulatable inter action hotspot for chromatin effector proteins (Fig. 4d) . By extension, perturbation of this region of the nucleosome through either aberrant PTM installation or mutation could lead to dysregulation of epige netic processes. Indeed, a mutation in the acidic patch (H2AE56Q) has recently been implicated in human uterine and ovarian carcinomas 30 . By performing a systematic analysis of the effects of nucleosome modifications on chromatin remodelling activity, we have generated a dataset that exists as a resource to drive the design of future biochemical and cellbased studies geared towards further understanding of ISWI regulation. We have also shown that the nucleosome acidic patch is generally required for ISWI remodelling and for the activity of chro matin remodelling enzymes spanning multiple remodelling families. Additionally, our data lead us to propose that the acidic patch is subject to dynamic regulation by nucleosome modifications. Lastly, the library developed herein will have broad utility in chromatin biochemistry, by allowing causal relationships between histone modifications and enzy matic outputs to be explored in an unbiased and quantitative manner. Supplementary Information is available in the online version of the paper. reviewer Information Nature thanks B. Cairns, F. Pugh and the other anonymous reviewer(s) for their contribution to the peer review of this work.
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Analytical methods. Analytical reversedphase HPLC (RPHPLC) was performed on an Agilent 1100 series instrument employing a Vydac C18 column (5 μ m, 4 × 150 mm) at a flow rate of 1 ml/min. Semipreparative scale purifications were performed on an Agilent 1100 series instrument employing a Vydac C18 semipre parative column (12 μ m, 10 mm × 250 mm) at a flow rate of 4 ml/min. Preparative scale purifications were conducted on a Waters DeltaPrep 4000 system equipped with a Waters 486 tunable detector (Waters). A Vydac C18 preparative column (15-20 μ m, 20 × 250 mm) was used at a flow rate of 20 ml/min. 0.1% TFA in water (HPLC solvent A) and 90% acetonitrile, 0.1% TFA in water (HPLC solvent B) were used as the mobile phases in all RPHPLC analyses and purifications. Electrospray ionisation mass spectrometry (ESIMS) analysis was conducted on a MicrOTOFQ II ESIQqTOF mass spectrometer (Bruker Daltonics). Production and purification of RCC1 and Sir3 constructs. Fulllength RCC1 (Uniprot ID: P18754) with an Nterminal 6× HisSUMO tag and a Cterminal GST tag and the BAH domain of Saccharomyces cerevisiae Sir3 6 with a Cterminal FLAG6× His tag were subcloned into bacterial expression plasmids (pET, Novagen) for protein production in Escherichia coli. In brief, BL21 Rosetta (DE3) cells were transfected with expression plasmids and grown in LB medium at 37 °C until they reached an OD 600 of 0.6. For the 6× His-SUMORCC1-GST construct, protein expression was induced by the addition of 0.6 mM IPTG overnight at 18 °C. For the Sir3-BAHFLAG-6× His construct, protein expression was induced by the addition of 0.6 mM IPTG for 1 h at 37 °C. Cells were harvested by centrifugation at 4,000g for 10 min at 4 °C, and cell pellets were washed twice with 10 ml of cold PBS per litre of culture. Cells were lysed in 10 ml lysis buffer (40 mM Tris, 1 M NaCl, 5 mM β mercaptoethanol, 10% glycerol, pH 7.7 at 4 °C) per litre of culture by passage through an EmulsiFlexC3 homogenizer (Avestin). Each protein was initially purified by NiNTA affinity chromatography. The 6× His-SUMO tag was cleaved from the RCC1 construct by Ulp1 protease, and removed by reverse NiNTA affinity chromatography. The RCC1-GST and Sir3-BAHFLAG-6× His constructs were further purified over Superdex 200 10/300 GL and Superdex 75 10/300 GL gel filtration columns (GE Healthcare) equilibrated with gel filtration buffer (50 mM Tris, 100 mM NaCl, 2 mM tris(2carboxyethyl)phosphine, 10% glycerol), respectively, using an AKTA FPLC system (GE Healthcare) equipped with a P920 pump and UPC900 monitor before use in subsequent experiments. Production and purification of recombinant histones. Unmodified recombinant human histones (H2A, Uniprot ID: Q6FI13; H2B, Uniprot ID: O60814; H3C96A, C110A, Uniprot ID: P68431; H4, Uniprot ID: P62805), histone variants, and histone mutants were produced in and purified from E. coli. In brief, BL21 Rosetta (DE3) cells were transfected with histone expression plasmids (pET, Novagen) and grown in LB medium at 37 °C until they reached an OD 600 of 0.6. Protein expression was induced by the addition of 0.6 mM IPTG for 2-3 h at 37 °C. Cells were harvested by centrifugation at 4,000g for 10 min at 4 °C, and cell pellets were washed twice with 10 ml of cold PBS per litre of culture. Cell pellets were resus pended in 10 ml of cold lysis buffer (50 mM Tris, 100 mM NaCl, 1 mM EDTA, 1 mM 2mercaptoethanol, pH 7.6 at 4 °C) with cOmplete, EDTAfree Protease Inhibitor Cocktail (SigmaAldrich) per litre of culture and homogenized by passage several times through an 18gauge needle. Cells were lysed via sonication and the resulting suspension was centrifuged at 30,000g for 30 min at 4 °C. The inclusion body pellet was washed twice with cold lysis buffer containing 1% TritonX 100 and once without detergent. Inclusion body pellets were resuspended in 10 ml inclu sion body resuspension buffer (6 M guanidine hydrochloride, 20 mM Tris, 1 mM EDTA, 100 mM NaCl, 1 mM DTT, pH 7.5 at 4 °C) per litre of culture, and nutated at 4 °C for 2 h. Resuspensions were then centrifuged at 30,000g for 30 min at 4 °C, and the supernatants were transferred to 3.5 kDa MW cutoff dialysis tubing and dialysed overnight in 2 l low salt urea buffer (7 M urea, 10 mM Tris, 1 mM EDTA, 100 mM NaCl, 1 mM DTT, pH 7.5 at 4 °C). Resuspensions were dialysed for an additional 2 h before loading onto a HiTrap SP HP 5ml column (GE Healthcare) equilibrated with low salt urea buffer (filtered and degassed). The histones were purified using a gradient over 20 column volumes from low salt urea buffer to high salt urea buffer (7 M urea, 10 mM Tris, 1 mM EDTA, 1 M NaCl, 1 mM DTT, pH 7.5 at 4 °C) on an AKTA FPLC system from GE Healthcare equipped with a P920 pump and UPC900 monitor. Histones were further purified using prepara tive C18 RPHPLC. Purified histones were analysed by analytical RPHPLC and ESIMS ( Supplementary Fig. 2 ). Production of modified histones by protein semi-synthesis. H2AK119ub, H2BK120ub, H3K4me3, H3K9ac, H3K9me3, H3K14ac, H3K18ac, H3K18acK23ac, H3K23ac, H3K27ac, H3K27me3, H3KpolyAc, H4K5ac, H4K8ac, H4K12ac, H4K16ac, H4K20ac, and H4KpolyAc histones were prepared by semisynthesis as described previously 18 . The semisynthesis of the H3R42me2a histone was conducted as described previously 31 . Preparation of H2AK5ac, H2AK9ac, H2AK13ac, H2AK15ac, and H2AKpolyAc histones. Proteins were assembled from two pieces: a recombinant fragment was generated encompassing residues 21-129 of histone H2A with an A21C mutation fused to an Nterminal 6× His-SUMO tag. This sequence was inserted into a pET expression plasmid and confirmed by gene sequencing. BL21 Rosetta (DE3) cells were transfected with the plasmid and grown in LB medium at 37 °C until they reached an OD 600 of 0.6. Protein expression was induced by the addition of 0.6 mM IPTG for 2-3 h. Cells were harvested, lysed, and inclusion bodies were prepared identically as for recombinant histones in this study. The 6× His-SUMO-H2A (21-129)A21C protein was purified by NiNTA affinity chromatography. The sample was dialysed for 2 h in 2 M urea, 50 mM Tris, 200 mM NaCl, 1 mM DTT, pH 7.4 at 4 °C before being moved to an otherwise identical buffer containing 1.5 M urea. Ulp1 protease was added to cleave off the 6× His-SUMO tag and the sample was dialysed overnight at 4 °C. The resulting H2A(21-129)A21C fragment was purified using preparative C18 RPHPLC. The final product was characterized by ESIMS and analytical C18 RPHPLC.
H2AK5ac, H2AK9ac, H2AK13ac, H2AK15ac, and H2AKpolyAc peptides corresponding to residues 1-20 with acetylated lysine residues at the indicated positions were synthesized as follows: approximately 500-750 mg TritylOH resin (ChemMatrix) was resuspended with 10 ml dichloromethane (DCM) and chlorinated by reaction with 200 μ l SOCl 2 on a shaker overnight. The resin was washed thoroughly with DCM and dimethylformamide (DMF) followed by an additional wash with 5% (v/v) N,Ndiisopropylethylamine (DIEA). 500 mg chlorinated resin was combined with a fourfold excess (relative to resin loading) of hydrazine monohydrate in 2 ml DMF along with an eightfold excess of DIEA. The reaction was stirred on ice for 1 h and subsequently washed with DMF before repeating the reaction with hydrazine/DIEA in DMF to ensure quantitative loading. To ensure all reactive sites on the resin had been consumed, after 1 h, 500 μ l methanol was added to the second hydrazine reaction and stirred for an additional 30 min.
The peptides were synthesized on a CEM Discover Microwave Peptide Synthesizer using Fmoc chemistry. Fmocacetyllysine was used to incorporate acetyllysine residues at the appropriate positions. For a 0.25 mmolscale reaction the resin was first swelled in DMF. In between, the resin was washed with DMF and DCM. Each amino acid was dissolved in DMF (200 mM) and introduced to the resin after the deprotection step. DIEA (2 M) in Nmethylpyrrolidone (NMP) and HOBt (500 mM)/HBTU (500 mM) in DMF were added along with the amino acid to perform each coupling (twice). The resin was then removed from the synthesizer without deprotecting the final Fmoc group for stability in storage. The N terminus of each peptide was manually deprotected with 20% piperidine and acetylated with acetic anhydride. Peptides were cleaved from the resin as Cterminal acyl hydrazides in 95% TFA, 2.5% triisopropylsilane (TIS), and 2.5% water and purified by preparative C18 RPHPLC. The final products were characterized by ESIMS and analytical C18 RPHPLC.
Fulllength histones were prepared by traceless native chemical ligation of acetylated peptides and the recombinant fragment as previously described 18 and purified by semipreparative C18 RPHPLC. Final products were characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2) . Preparation of the H2AK118ac histone. A recombinant fragment corresponding to residues 1-112 of H2A was fused to a fused Npu DnaE intein with a Cterminal 6× His tag. This protein was produced in E. coli and purified by NiNTA affinity chromatography. An α thioester was installed in the histone fragment by thiolysis (via 2mercaptoethanesulfonate) of the corresponding intein fusion using a method similar to that previously described 32 . An H2AK118ac peptide (113-129, A113C) was synthesized as described above (Preparation of H2AK5ac, H2AK9ac, H2AK13ac, H2AK15ac, and H2AKpolyAc histones), with minor modifications. The peptide was synthesized on Wang resin that was purchased precharged with the Cterminal amino acid (Bocprotected lysine). Acetylation of the Nterminal amine with acetic anhydride was omitted after final Fmoc deprotection, and the peptides were cleaved (95% TFA, 2.5% triisopropylsilane (TIS), and 2.5%) as Cterminal carboxylates. The fulllength histone was prepared by traceless native chemical ligation of acetylated peptide and the recombinant fragment as previously described 18 and subsequently purified by semipreparative C18 RPHPLC. The final product was characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2) . Preparation of H2BK5ac, H2BK11ac, H2BK12ac, H2BK15ac, H2BK16ac, and H2BK20ac histones. Proteins were assembled from two pieces: a recombinant fragment was generated encompassing residues 21-125 of histone H2B with an A21C mutation fused to an Nterminal 6× His-SUMO tag. This sequence was inserted into a pET expression plasmid and confirmed by gene sequencing. The recombinant H2B(21-125)A21C fragment was produced and purified using a method analogous to that described for the H2A(21-129)A21C fragment above (Preparation of H2AK5ac, H2AK9ac, H2AK13ac, H2AK15ac, and H2AKpolyAc histones). The final product was characterized by ESIMS and analytical C18 RPHPLC.
Letter reSeArCH
H2BK5ac, H2BK11ac, H2BK12ac, H2BK15ac, H2BK16ac, and H2BK20ac peptides corresponding to residues 1-20 with acetylated lysine residues at the indicated positions were synthesized by a method analogous to that described above (Preparation of H2AK5ac, H2AK9ac, H2AK13ac, H2AK15ac, and H2AKpolyAc histones), omitting acetylation of the Nterminal amine with acetic anhydride. Fulllength histones were prepared by traceless native chemical ligation of acetylated peptides and the recombinant fragment as previously described 18 and were purified by semipreparative C18 RPHPLC. The final products were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2) . Preparation of H2BK108ac, H2BK116ac, H2BK120ac, H2BK125ac histones. H2BK108ac, H2BK116ac, H2BK120ac, and H2BK125ac histones were produced in a similar manner to H2AK118ac as described above (Preparation of the H2AK118ac histone). A recombinant fragment corresponding to residues 1-106 of H2B containing an α thioester was prepared by thiolysis of fused Npu DnaE intein fusion for ligation to H2BK108ac(107-125, A107C) and H2BK116ac(107-125, A107C) peptides. In addition, a recombinant fragment corresponding to residues 1-116 of H2B containing an α thioester was prepared by thiolysis of a fused Npu DnaE intein fusion for ligation to H2BK120ac(117-125, A107C) and H2BK125ac(117-125, A117C) peptides. Fulllength histones were prepared by traceless native chemical ligation of acetylated peptides and the recombinant fragment as previously described 18 and were subsequently purified by semi preparative C18 RPHPLC. The final products were characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2 ). Preparation of phosphorylated H3 histones. The H3H41ph histone was prepared using a previously described threepiece traceless ligation strategy 31 with minor modifications. Notably, the middle peptide fragment (residues 29-46, A29C) was synthesized with inclusion of FmocTyr(PO(OBzl)OH)OH, which was used to introduce a phosphotyrosine residue at position 41 of H3. The H3S10ph histone was prepared using a twopiece traceless ligation strategy analogous to that described previously for ligation of synthetic peptide fragments corresponding to residues 1-14 of H3 to a recombinant H3 fragment corresponding to residues 15-135 (A15C, C96A, C110A)
18
. The Nterminal peptide fragment (residues 1-14) was synthesized with inclusion of FmocSer(PO(OBzl)OH)OH to introduce a phosphoserine residue at position 10 of H3. The final products were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2) . Preparation of H3K4me1 and H3K4me2 histones. H3K4me1 and H3K4me2 histones were prepared using a twopiece traceless ligation strategy analogous to that described previously for native chemical ligation of synthetic peptide fragments corresponding to residues 1-28 of H3 to a recombinant H3 fragment corresponding to residues 29-135 (A29C, C96A, C110A) 18 . The Nterminal peptide fragments (residues 1-28) were synthesized using Fmoc chemistry as previously described using an onresin alkylation strategy to generate mono and dimethylated lysine residues at position 4 of H3 33, 34 . The final products were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2) . Preparation of H3R2 methylated histones. H3R2me and H3R2me2a histones were prepared using a twopiece traceless ligation strategy analogous to that described previously for ligation of synthetic peptide fragments corresponding to residues 1-14 of H3 to a recombinant H3 fragment corresponding to residues 15-135 (A15C, C96A, C110A) 18 . The Nterminal peptide fragment (residues 1-14) was synthesized with inclusion of either FmocArg(Me,Pbf)OH or Fmoc ADMA(Pbf)OH to introduce either a monomethyl or asymmetric dimethyl arginine residue at position 2 of H3. The final products were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2) . Preparation of the H3K36me3 histone. The H3K36me3 histone was prepared with a threepiece ligation strategy analogous to that previously described 31 with minor modifications. Notably, the fulllength sequence corresponded to H3 and contained C96A, C110A mutations, and the middle peptide fragment (residues 29-46, A29C) was synthesized with inclusion of FmocLys(Me 3 )OH, which was used to introduce a trimethyllysine residue at position 36 of H3. The final product was characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2) . Preparation of H4R3 methylated histones. Synthetic H4 peptides were assembled as alkylthioesters (TAMPAL) 35 on solid phase. Up to residue 4, amino acids were incorporated using Bocprotected amino acids and in situ neutralization protocols. Sidechain protected amino acids (H4(1-14)R3Me and R3Me2s) were coupled using standard HBTU/DIPEA (2(1Hbenzotriazol1yl)1,1,3,3tetramethyluronium hexafluorophosphate/diisopropylethylamine) procedures; subsequent couplings were carried out using Fmoc amino acids, thus maintaining acid sensitive side chain protecting groups (for example, Boc or Pbf). To reduce Fmocdeprotection cocktail exposure time, the terminal residue could be coupled with Boc protection. Final Fmoc deprotection was carried out in 1methylpyrrolidine (25% v/v), hexamethylene imine (2% v/v), HOBt (2% w/v), in NMPDMSO (1:1); (2) DBU (1% v/v), HOBt (1% w/v) in DMF.
The H4(1-14)R3Me2a thioester peptide was synthesized using resin from above that was split before coupling methyl arginine residues. Following Boc deprotection, neutralization of the TFA salt (5% (v/v) DIPEADMF), and thorough washing with DMF, the resin was washed with 5% (w/v) HOBtDMF, ensuring the slightly acidic environment necessary to maintain arginine side chain protonation. Subsequent basefree activation of FmocADMA, in the presence of peptidylresin, was achieved using 5 eq of FmocADMAOH, 5 eq of N,Ndiisopropylcarbodiimide (DIC) and 5.5 eq of HOBt in 10% DMFDCM, with excess HOBt used to maintain sidechain protonation. Fmocdeprotection was subsequently mediated using 1methylpyrrolidine (25% v/v), hexamethylene imine (2% v/v), HOBt (2% w/v), in NMPDMSO (1:1); 36 (2) DBU (1% v/v), HOBt (1% w/v) in DMF, and the described coupling process repeated for subsequent amino acids, with neutralization omitted following Fmocdeprotection.
Peptides were cleaved from the resin using liquid HF. HF cleavage (10 ml HF/g resin) was performed for 1.5 h at 0-4 °C with 5% (v/v) pcresol as a scavenger. Following HF cleavage, the HF was removed under reduced pressure, peptides were precipitated in icecold ether, filtered, dissolved in 40% (v/v) aqueous MeCN containing 0.1% (v/v) TFA, and lyophilized. Peptides were purified by preparative C18 RPHPLC and final products were characterized by analytical C18 RPHPLC and ESIMS.
To generate the remaining recombinant portion of H4 suitable for native chemical ligation, the H4(1-14) tail was fused to the hexahistidinetagged, thrombin cleavable truncated H4 protein bearing an A15C mutation; insertion of the Histag and thrombin cleavage sequence into the H4 protein between residues 14 and 15 was found to improve expression levels. This approach yielded protein as inclusion bodies, which after Ni 2+ affinity chromatography was subjected to oncolumn cleavage with thrombin. By incorporating a mutated thrombin cleavage site (LVPRC), the desired Nterminal cysteine containing H4 fragment could be obtained by extracting the cleaved protein from the column using 8 M urea. The truncated histones were then further purified by preparative C18 RPHPLC.
Native chemical ligation was performed in 0.1 M sodium phosphate pH 7.5, 6 M guanidineHCl, 0.1 M NaCl, 60 mM TCEP, 30 mM 4mercaptophenylacetic acid (MPAA) at 37 °C. Reactions were performed at approximately 3 mM peptide concentration in siliconized 1.5mL microcentrifuge tubes. Substantially lower yields were obtained when standard polypropylene tubes were used. Ligation products were purified, desulfurized, and purified by a method analogous to that previously described 18 . Final protein products were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2 ). Preparation of H4K77ac and H4K79ac histones. H4K77ac and H4K79ac histones were produced by a similar method to that described above (Preparation of the H2AK118ac histone). A recombinant fragment corresponding to residues 1-75 of H4 containing an α thioester was prepared by thiolysis of a fused Npu DnaE intein fusion for ligation to H4K77ac(76-102, A76C) and H4K79ac(76-102, A76C) peptides. Fulllength histones were prepared by traceless native chemical ligation of acetylated peptides and the recombinant fragment analogous to that previously described 18 and were subsequently purified by semipreparative C18 RPHPLC. The final products were characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2) . Preparation of H2BS112GlcNAc. FmocSer(β DGlcNAc(Ac) 3 )OH was synthesized as previously described (using aglycone FmocSer(OH)OBn and glycosyl donor GlcNTroc(Ac) 3 Br) 37 for use in solidphase peptide synthesis. Standard Fmoc solidphase peptide synthesis was used to access the glycopep tide H2B(107-125, S112GlcNAc, A107C). After successful peptide assembly, the peracetylated glycopeptide was deprotected on resin by hydrazinolysis 37 , cleaved from the resin, and purified by preparative C18 RPHPLC. The H2B(1-106) α thioester was obtained by expression and thiolysis of a recombinant intein fusion fragment of H2B, H2B(1-106)GyrAHis 6 as previously described 32 . A onepot ligation-desulfurization procedure 38 was used to obtain the final glycosylated H2BS112GlcNAc, histone which was purified by semipreparative C18 RPHPLC. The final product was characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 2 ). Production and purification of modified histones by amber suppression. All crotonylated histones were produced using amber suppression in E. coli as previously described 39, 40 . Preparation of H3K4ac, H3K36ac, H3K37ac, H3K56ac, H3K64ac, H3K79ac, H3K115ac, H3K122ac, and H4K91ac histones. H3K4ac, H3K36ac, H3K37ac, H3K56ac, H3K64ac, H3K79ac, H3K115ac, H3K122ac histones were prepared by fusing a fused Npu DnaE intein to the C terminus of H3 (H3C96A, C110A) or H4 and produced using amber suppression in E. coli as previously described 12, 41 . Following purification, all proteins were characterized by analytical C18 RPHPLC and ESIMS (Supplementary Fig. 2) . Synthesis of LANA peptides. Two LANA peptides 8 corresponding to residues 2-22 with a norleucine at position 6 substituted for methionine were prepared. The Letter reSeArCH first contained the otherwise native sequence, and the second had residues 8-10 (LRS) mutated to alanine, which is known to hinder nucleosome binding 8 . Peptides were synthesized on a CEM Discover Microwave Peptide Synthesizer using Fmoc chemistry and a ChemMatrix Rink amide resin (0.47 mmol/g). Following chain assembly, peptides were cleaved from the resin using 95% TFA, 2.5% TIS, and 2.5% water and purified by C18 RPHPLC. Final products were characterized by analytical C18 RPHPLC and ESIMS ( Supplementary Fig. 4) . Production of chromatin remodellers in Sf9 cells. All chromatin remodellers used in this study were produced in Sf9 cells using a baculovirus expression vector system. The SNF2h (Uniprot ID: O60264), ACF1 (Uniprot ID: Q9NRL2), WSTF (Uniprot ID: Q9UIG0), CHRAC15 (Uniprot ID: Q9NRG0), and CHRAC17 (Uniprot ID: Q9NRF9) coding sequences were a gift from R. Kingston (Harvard University). The RSF1 (Uniprot ID: Q96T23) coding sequence was a gift from D. Reinberg (New York University). The BPTF (Uniprot ID: Q12830, isoform 4) coding sequence was a gift from C. D. Allis (Rockefeller University). The SNFL, TIP5 (Uniprot ID: Q9UIF9, isoform 1), CHD4 (Uniprot ID: Q14839), and RbAp46 (Uniprot ID: Q16576) coding sequences were purchased from Open Biosystems. The SNF2L coding sequence was purchased as an inactive splice variant 42 with an insertion that was deleted using standard molecular cloning procedures to yield the active variant (Uniprot ID: P28370, isoform 2). pFastBac1Flag-BRG1 was a gift from R. Kingston (Addgene plasmid # 1957) 43 . All coding sequences were confirmed by Sanger sequencing. All coding sequences were subcloned into vectors compatible with bacmid generation by standard restriction enzyme cloning methods or Gibson Assembly (NEB) with FLAG affinity tags introduced suitable for purification of all desired proteins and protein complexes (flag denotes N or Cterminal FLAG affinity tag): pFastBac1SNF2h-flag, pACEBac1SNF2h, pACEBac1ACF1-flag, pACEBac1WSTF-flag, pACEBac1CHRAC15, pACEBac1CHRAC17, pACEBac1TIP5-flag, pACEBac1flag-RSF1, pFastBac1flag-BPTF, pACEBac1RbAp46, pACEBac1SNF2L, and pACEBac1CHD4-flag. For bacmid generation, SNF2h, ACF1-flag, WSTF-flag, CHRACH15, CHRAC17, TIP5-flag, flag-RSF1, CHD4-flag constructs were transfected in to DH10MultiBacTurbo E. coli competent cells, and bacmids were produced per manufacturer's instructions (Geneva Biotech). SNF2h-flag, flag-BPTF, SNF2L, RbAp46, and flag-BRG1 constructs were transfected into DH10bac E. coli competent cells, and bacmids were produced per manufacturer's instructions (BactoBac Baculovirus Expression System, ThermoFisher Scientific). To generate virus for protein production, bacmid transfection into Sf9 cells was carried out in 6well plates. All transfection, viral amplification, and infection steps were per formed in a sterile hood. Typically, 1-10 μ g of bacmid was transfected into 1 × 10 6 attached Sf9 cells according to the manufacturer's instructions (BactoBac Baculovirus Expression System, ThermoFisher Scientific). After transfection, cells were overlaid with 2 ml fresh medium (Sf900III SFM, Thermo Fisher Scientific) and incubated at 27 °C for 72 h in the dark. The supernatant was collected for virus amplification and cleared by centrifugation to generate the P1 virus. 2% FBS (v/v) was added. Between uses, all viral stocks were stored at 4 °C in the dark. Subsequent steps were carried out in medium with penicillin/streptomycin. To generate the P2 virus, 800 μ l P1 virus was added to 20 ml of Sf9 cells in a sterile flask at 2 × 10 6 cells per ml. Cells were grown at 27 °C in suspension culture in the dark until they reached 40% viability as monitored by trypan blue staining. The culture superna tant was then collected and cleared by centrifugation, and 2% FBS (v/v) was added. To generate the P3 virus (used for protein production), 200 μ l P2 virus was added to 50 ml of Sf9 cells in a sterile flask at 2 × 10 6 cells per ml. Cells were grown at 27 °C in suspension culture in the dark until they reached 40% viability as monitored by trypan blue staining. The culture supernatant was then collected and cleared by centrifugation, and 2% FBS (v/v) was added. During virus amplification Sf9 cell density was kept at around 2 × 10 6 cells per ml, diluting if needed, until growth arrested and viability dropped. Aside from the monomeric SNF2h (SNF2h-flag), CHD4 (CHD4-flag), and BRG1 (flag-BRG1) ATPases, individual viruses were directly combined with Sf9 cell cultures to generate the ACF (ACF1-flag, SNF2h), CHRAC (ACF1-flag, SNF2h, CHRACH15, CHRAC17), WICH (WSTF-flag, SNF2h), NoRC (TIP5-flag, SNF2h), RSF (flag-RSF1, SNF2h), and NURF (flag-BPTF, SNF2L, RbAp46) complexes. Production of CHD4 and the ACF, CHRAC, WICH, NoRC, and RSF complexes was carried out by adding a 1:1,000 dilution of each P3 virus to Sf9 suspension cultures at 2 × 10 6 cells per ml. Cells were harvested by centrifugation after 72 h at 27 °C in the dark. Production of SNF2h, BRG1, and the NURF complex was carried out by adding a 1:100 dilution of P3 virus to Sf9 suspension cultures at 2 × 10 6 cells per ml. Cells were harvested by centrifugation after 48 h at 27 °C in the dark. All proteins and protein complexes were purified by first washing harvested cell pellets with 10 ml of cold TBS (50 mM Tris, 150 mM NaCl, pH 7.5 at 4 °C) per 50 ml of culture. Washed pellets were resuspended in 400 μ l of cold nuclear extraction buffer A (buffer A; 10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA) with 1 mM DTT, cOmplete, EDTAfree Protease Inhibitor Cocktail (SigmaAldrich), and 0.5 mM PMSF per 10 ml of suspension culture and swelled on ice for 15 min. 25 μ l of 10% IGEPAL CA630 per 400 μ l of buffer A were then added, and the cells were vortexed briefly for lysis. Nuclei were spun down at 4 °C for 30 s at 17,000g and the supernatant was removed. The nuclei were washed once with 400 μ l of cold buffer A (with 1 mM DTT, cOmplete, EDTAfree Protease Inhibitor Cocktail, and 0.5 mM PMSF) per 10 ml of suspension culture. The resulting nuclear pellet was resuspended in 50 μ l of cold nuclear extraction buffer B (buffer B, 20 mM HEPES, pH 7.9, 400 mM KCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol) with 1 mM DTT, cOmplete, EDTAfree Protease Inhibitor Cocktail, and 0.5 mM PMSF per 10 ml of suspension culture. Nuclear pellets were then incubated with endoverend rotation for 15 min at 4 °C. Nuclear debris was then spun down at 4 °C for 10 min at 17,000g. The supernatant (nuclear extract) was removed for FLAG affinity purification of remodellers. 1.5 μ l (3 μ l of 50% slurry) of antiFLAG M2 beads (SigmaAldrich) per millilitre of suspension culture were used for purification. First, beads were washed twice with 10 bead volumes of BC100 buffer (20 mM HEPES, 100 mM KCl, 0.2 mM EDTA, 10% glycerol, 1 mM DTT, 0.2 mM PMSF, pH 7.9). The nuclear extract was diluted twofold with BC0 buffer (BC100 buffer without KCl) and centrifuged at ≥ 4,000g for 10 min at 4 °C. The supernatant was removed from any precipitation, added directly to the washed antiFLAG M2 beads, and incubated for 1 h at 4 °C with endoverend rotation. The beads were centrifuged for 5 min at 1,000g and 4 °C, and the supernatant was removed. The beads were washed once with 10 bead volumes of BC100 buffer, once with 10 bead volumes of BC300 buffer (BC100 buffer with 300 mM KCl), and once with 10 bead volumes of BC100 buffer. Bound protein was eluted by incubation with one bead volume of 0.25 mg/ml FLAG peptide (SigmaAldrich) in BC100 buffer for 20 min at 4 °C. This process was repeated twice. Pure elutions were combined and concentrated using appropriate molecular weight cutoff Vivaspin 500 centrifugal filter units (Vivaproducts) if needed. Concentrations of remodellers were determined using BSA standards and SDS-PAGE with Coomassie blue staining referencing the intensity of the ATPase subunit for each complex. Following purification, remodellers were aliquoted, flashfrozen in liquid nitrogen and stored at − 80 °C until use. The purity of ISWI family remodellers (Extended Data Fig. 3a) as well as BRG1 and CHD4 ( Supplementary Fig. 5a ) was assessed by SDS-PAGE analysis and Coomassie blue staining. Additionally, ATPdependent nucleosome remodelling activity on unmodified nucleosomes was verified for ISWI family members (Extended Data Fig. 3b ) as well as BRG1 and CHD4 ( Supplementary Fig. 5b ) using a restriction enzyme accessibility assay. All assays were performed in 50 μ l reactions with 10 nM unmodified nucleosomes under conditions described below (Nucleosome remod elling rate analysis for validation experiments on single nucleosomes). Time points were taken at 1 min and 60 min, quenched, and deproteinized as described below (Remodelling assays using the nucleosome library). Samples were directly run on a 5% polyacrylamide gel (0.5× TBE, 200 V, 40 min). Staining was performed with SYBR Safe DNA gel stain, and gels were imaged on a Typhoon scanner (GE Healthcare). Each remodeller was analysed in the presence and absence of 2 mM ATP. In all cases, the appearance of a lower band at 60 min that is dependent on the presence of ATP (indicative of remodelling) was visible. The plasmid was produced in and purified from DH5α cells as previously described 44 . Approximately 20 mg of plasmid was obtained from 6 l bacterial culture. Ten milligrams of the plasmid was then digested with BsaI and DraIII (total DNA concentration of 1 mg/ml in the presence of 500 U/ml of each restric tion enzyme) at 37 °C overnight. Digested DNA was purified by phenol chloroform extraction and concentrated by ethanol precipitation. The pellet was resuspended in roughly 1 ml of TE buffer (50 mM Tris, 0.1 mM EDTA, pH 7.5) and sucrose was added to a final concentration of 15%. The desired fragment was then purified by polyacrylamide gel electrophoresis (5% polyacrylamide gel, 0.5× TBE buffer) using a preparative cell (BioRad). A peristaltic pump inline with a Foxy R1 fraction collector (Teledyne Isco) was used to collect eluting fractions every 45 s at a flow rate of 1 ml/min. Fractions containing the desired fragment were pooled and concentrated by ethanol precipitation. The pellet was resuspended in water yielding approximately 1-2 mg of 601 DNA. Unique nucleosome identifier barcodes were then individually ligated to 601 DNA fragment using the non palindromic 5′ DraIII site. Individual oligo pairs were purchased from Integrated DNA Technologies. Each oligo was dissolved in TE buffer to a concentration of roughly 100 μ M. For hybridization, equimolar amounts of oligo pairs (top and bottom strand) were mixed at a concentration of 10 μ M each oligo in a volume of 500 μ l. Samples were heated on a heat block for 5 min at 95 °C, and were sub sequently left to cool slowly by placing the heat block on a laboratory benchtop at room temperature for 1 h. Individual oligos contained the following sequence (bold, partial Illumina forward adaptor sequence; underline, unique hexanucleo tide nucleosome identifier barcode):
Top strand: 5′CTCTTTCCCTACACGACGCTCTTCCGATCTNNNN NNCACCGC3′ Bottom strand: 5′GTGNNNNNNAGATCGGAAGAGCGTCGT GTAGGGAAAGAGAA3′
A list of the unique hexanucleotide nucleosome identifier barcodes used in this study can be found in Supplementary Table 5 . Relative to the top strand, hybridi zation resulted in doublestranded BC DNA with a 3′ overhang compatible with ligation to the 5′ DraIII overhang on the purified 601 sequence and a 3′ AA dinu cleotide overhang to prevent bluntend ligation of hybridized oligos. In a typical ligation reaction, 0.41 μ M of 601 DNA was combined with 1.2 equivalents of double stranded BC DNA and incubated at 37 °C with 0.1 U/μ l T4 polynucleotide kinase (NEB) in a total volume of 100 μ l in 1× T4 ligase buffer (NEB) for 1 h. Subsequently 5 U/μ l T4 DNA ligase were added, and the mixture was incubated for 1 h at room temperature. Ligation reactions were monitored by native polyacrylamide gel electrophoresis (5% polyacrylamide gel, 0.5× TBE, 200 V, 40 min) and staining with SYBR Safe DNA gel stain (ThermoFisher Scientific; Extended Data Fig. 1a) . The final product was purified using a Qiagen PCR purification kit and quantified by UV spectroscopy at 260 nm. The final product resulted in a 192bp DNA fragment composed of the 147bp 601 sequence and a 45bp overhang containing a unique hexanucleotide barcode and a partial Illumina forward adaptor sequence (bold, 601 sequence; bold underline, PstI site; underline, unique hexanucleotide nucleosome identifier barcode):
5′ CTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNCACCGCGTG ACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCC CTTGGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGG TGCTAGAGCTGTCTACGACCAATTGAGCGGCTGCAGCACCGGGATTCT CCAG3′
The partial Illumina forward adaptor sequence is the 30 bp 5′ of the hexanu cleotide barcode.
CpG methylated nucleosomal DNA was prepared as described in Extended Data Fig. 1b .
Biotinylated MMTV 'buffer' DNA. Biotinylated mouse mammary tumor virus (MMTV) 'buffer' DNA was prepared by PCR using a MMTV DNA template 45 with the following primers purchased from Integrated DNA Technologies:
Forward: 5′ biotin-TATCACTTGCAACAGTCCTAACATTCACCTC3′ (HPLC purified)
Reverse: 5′ ATCCAAAAAACTGTGCCGCAGTCGG3′ The PCR product was purified using a Qiagen PCR purification kit. The final product was quantified by UV spectroscopy at 260 nm and stored at − 20 °C. 192-bp DNA fragment used in follow-up studies on individual nucleosomes. 601 DNA used in nonlibrary remodelling assays on individual nucleosomes was generated via PCR. The 147bp 601 sequence containing a PstI site was inserted into a KS BlueWhite screening vector using standard restriction enzyme techniques. Primers were designed to amplify the 601 sequence with a 45bp overhang generated from the surrounding vector sequence.
Forward: 5′ GGCCGCTCTAGAACTAGT3′ Reverse: 5′ CTGGAGAATCCCGGT3′ DNA fragment generated (bold, 601 sequence; underlined, PstI site): GGCCGCTCTAGAACTAGTGGATCCGATATCGCTGTTCACCGCGTGAC AGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTT GGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTG CTAGAGCTGTCTACGACCAATTGAGCGGCTGCAGCACCGGGATTCTCC AG Octamer formation for the nucleosome library. Octamers containing desired histone compositions were assembled as previously described 18 with minor modifi cations. In brief, histones were dissolved in histone unfolding buffer (6 M guanidine hydrochloride, 20 mM Tris, 5 mM DTT, pH 7.5 at 4 °C) and combined in equimolar ratios (0.75 nmol each of desired version of histones H2A, H2B, H3, and H4). The total histone concentration was adjusted to 1 mg/ml, and the mixtures were placed in SlideALyzer MINI dialysis devices (3.5 kDa MW cutoff, ThermoFisher Scientific) and dialysed at 4 °C against 3 × 400 ml of octamer refolding buffer (2 M NaCl, 10 mM Tris, 0.5 mM EDTA, 1 mM DTT, pH 7.8 at 4 °C) for at least 4 h for each step, with one dialysis step overnight. The mixtures were then transferred to clean microcentrifuge tubes and spun down at 17,000g for 5 min at 4 °C to remove any precipitate. Supernatants were transferred to fresh microcentrifuge tubes, and 50% (v/v) glycerol was added. Octamer concentrations were measured by UV spectroscopy at 280 nm, and stored at − 20 °C until use in nucleosome assembly. Nucleosome reconstitution for the nucleosome library. Nucleosomes were assembled as previously described 18 with minor modifications. In brief, in a typical nucleosome assembly, a crude histone octamer preparation (50 pmol) was combined with the appropriate BC601 DNA (25 pmol) and biotinylated MMTV 'buffer' DNA (25 pmol) in 70 μ l octamer refolding buffer (2 M NaCl, 10 mM Tris, 0.5 mM EDTA, 1 mM DTT, pH 7.8 at 4 °C). Mixtures were placed in SlideALyzer MINI dialysis devices (3.5 kDa MW cutoff, ThermoFisher Scientific) and dialysed at 4 °C against 200 ml nucleosome assembly start buffer (10 mM Tris, 1.4 M KCl, 0.1 mM EDTA, 1 mM DTT, pH 7.8 at 4 °C) for 1 h at 4 °C. Subsequently, 330 ml nucleosome assembly end buffer (10 mM Tris, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, pH 7.8 at 4 °C) was added at a rate of 1 ml/min using a peristaltic pump, followed by two final dialysis steps against nucleosome assembly end buffer (1 h and overnight). The dialysis mixture was transferred to a microcentrifuge tube, and removal of biotinylated MMTV 'buffer' DNAassociated side products was accomplished by affinity depletion using 140 μ l MyOne streptavidin T1 coated Dynabead slurry (ThermoFisher Scientific) for 1 h at room temperature. The unbound material in the supernatant was transferred to a clean microcentrifuge tube, and any precipitate was removed by centrifugation. Final nucleosome prepa rations were quantified by UV spectroscopy at 260 nm. The quality of individual nucleosomes was assessed by native polyacrylamide gel electrophoresis (5% acrylamide gel, 0.5× TBE, 200 V, 40 min), followed by ethidium bromide staining. This resulted in a main band migrating around 500 bp (variable depending on the nucleosome variant; Extended Data Fig. 2a) . To form the library, nucleosome preparations were directly combined and concentrated using Vivaspin 500 centrifugal filter units (10 kDa MW cutoff, Vivaproducts). The final nucleosome library was analysed by native gel electrophoresis as previously described (Extended Data Fig. 2b ). For storage, 20% (v/v) glycerol was added resulting in a final library concentration of approximately 1.5 μ M. Library aliquots were flash frozen in liquid nitrogen, and stored at − 80 °C until being thawed before use. Analysis of nucleosome library integrity by antibody pull-down. We assessed nucleosome library integrity by antibody pulldown against a specific histone mark. The nucleosome library (12 fmol of each member) was combined with a modificationspecific antibody (antiH3K4me3, Abcam: ab8580; 15 μ g/ml final concentration) in 100 μ l antibody binding buffer (20 mM Tris, 50 mM NaCl, 5 mM EDTA, 0.1% TWEEN 20) and incubated at room temperature for 1 h. The volume was then brought to a final volume of 200 μ l with antibody binding buffer. Ten microlitres of Pierce Protein G agarose slurry (previously washed with antibody binding buffer) was then added and the mixture was incubated for an additional hour at room temperature to allow antibody binding to the Protein G beads. The beads were then washed four times with antibody binding buffer and incubated with 100 μ l elution buffer (100 mM Tris, pH 7.5, 10 mM EDTA, 1% SDS, 10 mM, 2mercaptoethanol, 8 U/ml proteinase K) for 90 min at 50 °C. DNA was purified using a Qiagen PCR purification kit, and was subsequently quantified using a Qubit highsensitivity dsDNA quantification kit. DNA was diluted with water to a final concentration of approximately 2 pg/μ l. The sample was PCR amplified according to conditions described below (Addition of multiplex barcodes and Illumina forward and reverse adaptor sequences via PCR). An input sample was prepared by directly mixing an equivalent amount of nucleosome library with elution buffer followed by identical sample processing. Sequencing was performed as described in the section 'Illumina sequencing' . Experimental samples were normalized against the input, and, within the experiment, the indicated variant (Extended Data Fig. 2c) . Nucleosome thermal mobility shift experiments. Nucleosome thermal mobility shift experiments were performed using a method similar to that previously described 45 . Octamers and nucleosomes were prepared in a way similar to that previously described 44 with minor modifications. Nucleosomes were assembled via salt gradient dialysis on a DNA fragment that was PCR amplified from a pTF vector to generate a 283bp fragment containing a centrally positioned MMTV sequence (NucA) 45 with 64 bp of flanking DNA on each side. Forward: 5′ ATTTATTATGCATTTAGAATAAATTTTGTGTCGCCCTTG3′ Reverse: 5′ CAGTCGAAAGACTGGGCCTTTC3′ DNA fragment generated (bold, MMTV sequence):
Approximately 1 pmol of each nucleosome type was incubated in assay buffer (50 mM Tris, 150 mM NaCl, pH 7.5) for 1 h at 37 °C or 47 °C. After incubation, 5 μ l Letter reSeArCH of 50% sucrose was added to each sample and the samples were run on a 5% TBE gel in 0.5× TBE buffer for 40 min at 200 V. Nucleosomes were visualized by staining with SYBR Gold Nucleic Acid Gel Stain (ThermoFisher Scientific). Unmodified and H3K14cr nucleosomes are not expected to be as mobile as H3T118H and H4R45A nucleosomes, which contain mutations that affect interactions between histones and DNA. Experiments using the nucleosome library. Remodelling assays using the nucleosome library. Remodelling assays used a restriction enzyme accessibility (REA)based strategy and were performed similarly to those previously described 19 . In each remodelling reaction, 10 nM of library was used along with varying amounts of remodelling enzyme depending on the baseline activity of each protein preparation. Typically, an amount of remodeller that resulted in approxi mately 50% of unmodified nucleosomes remodelled in 1 h was used (200 nM SNF2h, 2 nM ACF, 5 nM CHRAC, 10 nM WICH, 5 nM NoRC, 40 nM RSF, 5 nM CHD4 and 50 nM NURF). Fifty microlitre remodelling assays were carried out in REA buffer (12 mM HEPES, pH 7.9, 4 mM Tris, pH 7.5, 60 mM KCl, 10 mM MgCl 2 , 10% glycerol, and 0.02% (v/v) IGEPAL CA630) with or without 2 mM ATP and in the presence of 2 U/μ l PstI restriction enzyme (NEB). Reactions were preincubated for 10 min at 30 °C before initiation by the addition of nucleosomes. Note that ATP (or an equivalent volume of REA buffer in the case of reactions without ATP) was not added until approximately 2.5 min before initiation. After initiation, remodelling assays were carried out for 1 h at 30 °C. Six microliter samples were taken at 1, 2.5, 5, 15, 30, and 60 min and each was quenched with 9 μ l quench buffer (10% glycerol, 70 mM EDTA, pH 8, 20 mM Tris, pH 7.7, 2% SDS, 0.2 mg/ml bromophenol blue). Samples were deproteinized with 30 U/ml proteinase K (NEB) for 1 h at 37 °C. DNA was purified using a Qiagen PCR purification kit, eluting in 50 μ l TE buffer (50 mM Tris, 0.1 mM EDTA, pH 7.5). For each enzyme, reactions with and without ATP were performed in triplicate. With six time points taken per reaction, this generated 36 samples per enzyme analysed. Samples were quantified using a Qubit highsensitivity dsDNA quantification kit. DNA was diluted with water to a final concentration of approximately 2 pg/μ l. The sample was then PCR amplified as per conditions described in the section ' Addition of multiplex barcodes and Illumina forward and reverse adaptor sequences via PCR' .
Pull-down experiments with the RCC1-GST construct using the nucleosome library.
Ten microlitres of Pierce Glutathione Agarose slurry was washed four times with 100 μ l binding buffer (20 mM Tris, 50 mM NaCl, 5 mM EDTA 0.1% TWEEN 20, pH 7.5). The beads were resuspended in 100 μ l binding buffer after the final wash and 1.5 pmol RCC1-GST was added. Binding to the beads was allowed to occur for 1.5 h at room temperature with endoverend rotation. After incubation, the beads were washed again four times with 100 μ l binding buffer. The beads were resuspended in 100 μ l binding buffer after the final wash and combined with the nucleosome library (12 fmol of each member). After incubation with endover end rotation for 2 h at 4 °C, the beads were washed again four times with 100 μ l binding buffer. The beads were then directly resuspended in 100 μ l of DNA elution buffer (100 mM Tris, 10 mM EDTA, 1% SDS, 10 mM β mercaptoethanol, 200 μ g/ml proteinase K) and incubated for 1.5 h at 50 °C. At this point, an input sample for normalization was prepared by taking a small amount of nucleosome library, resus pending it in 100 μ l DNA elution buffer, and incubating for 1.5 h at 50 °C. DNA from all samples was purified using a Qiagen PCR purification kit, eluting in 50 μ l TE buffer (50 mM Tris, 0.1 mM EDTA, pH 7.5). Samples were quantified using a Qubit highsensitivity dsDNA quantification kit. DNA was diluted with water to a final concentration of approximately 2 pg/μ l. The sample was then PCR amplified as per conditions described in the section ' Addition of multiplex barcodes and Illumina forward and reverse adaptor sequences via PCR' . Pull-down experiments with the Sir3-BAH-FLAG-6×His construct using the nucleosome library. Ten microlitres antiFLAG M2 (SigmaAldrich) slurry was washed four times with 100 μ l binding buffer (20 mM Tris, 50 mM NaCl, 5 mM EDTA 0.1% TWEEN 20, pH 7.5). The beads were resuspended in 50 μ l binding buffer after the final wash and 40 pmol Sir3BAH-FLAG-6× His was added. Binding to the beads was allowed to occur for 1 h at room temperature with end overend rotation. After incubation, the beads were washed again four times with 50 μ l binding buffer. The beads were resuspended in 40 μ l binding buffer after the final wash and combined with the nucleosome library at a final concentration of 40 nM. After incubation with endoverend rotation for 1 h at room temperature, the beads were washed again four times with 50 μ l binding buffer. The beads were then directly resuspended in 100 μ l DNA elution buffer (100 mM Tris, 10 mM EDTA, 1% SDS, 10 mM β mercaptoethanol, 200 μ g/ml proteinase K) and incubated for 1.5 h at 50 °C. At this point an input sample for normalization was prepared by taking a small amount of nucleosome library, resuspending it in 100 μ l DNA elution buffer, and incubating for 1.5 h at 50 °C. DNA from all samples was purified using a Qiagen PCR purification kit, eluting in 50 μ l TE buffer (50 mM Tris, 0.1 mM EDTA, pH 7.5). Samples were quantified using a Qubit highsensitivity dsDNA quantifi cation kit. DNA was diluted with water to a final concentration of approxi mately 2 pg/μ l. The sample was then PCR amplified as per conditions described below (Addition of multiplex barcodes and Illumina forward and reverse adaptor sequences via PCR). Addition of multiplex barcodes and Illumina forward and reverse adaptor sequences via PCR. Approximately 10 pg DNA from each purified experimental sample collected from remodelling assays or binding experiments using the nucleosome library was added to a PCR reaction to be amplified using the following primer pair (XXXXXX, unique hexanucleotide multiplexing barcode):
Forward primer: 5′ AATGATACGGCGACCACCGAGATCTACACTCTT TCCCTACACGACG3′
Reverse primer: 5′ CAAGCAGAAGACGGCATACGAGATXXXXXX CTGGAGAATCCCGGTG3′
A list of the unique hexanucleotide multiplexing barcodes used in this study can be found in Supplementary Table 6 . Specific amplification of fulllength (uncut) nucleosomal DNA at each assay time point was carried out using a Phusion High Fidelity PCR kit from NEB and primers flanking the PstI restriction cut site (1 mM dNTPs, 10 pg DNA, 0.5 μ M each primer, 0.02 U/μ l polymerase) with the following amplification conditions: step 1: 98 °C for 30 s; step 2: 98 °C for 10 s; step 3: 47 °C for 15 s; step 4: 72 °C for 8 s. Steps 2-4 were repeated for 15 cycles followed by a final extension step at 72 °C for 7 min. To ensure reactions remained in the exponential phase and relative abundances of DNA fragments were maintained, qPCR analysis was performed using 10 pg of a chosen remodelling reaction time point using SYBR Green I Dye for detection on an ABI 7900 quantitative PCR instrument. Identical conditions were used as previously described except a 10s extension time was used (instead of 8 s) owing to the instrument requirements. A mean C t value of 13.9 was determined (compare to 15 cycles used for amplification of DNA before Illumina sequencing). The following amplicon was generated that is compatible with Illumina sequencing (bold, 601 sequence; bold underlined, PstI site; NNNNNN, unique hexanucleotide nucleosome identifier barcode; XXXXXX, unique hexanucleotide multiplexing barcode):
The full Illumina forward adaptor sequence is 5′ of the unique hexanucleotide nucleosome identifier barcode (NNNNNN). The full Illumina reverse adaptor sequence is 3′ of the unique hexanucleotide multiplexing barcode (XXXXXX). Samples containing unique multiplexing barcodes could be pooled directly after PCR and purified using a Qiagen PCR purification kit in one pot. After purifica tion, samples were subjected to highthroughput DNA sequencing as described in the methods section 'Illumina sequencing' . In each case, the correct amplicon size (250 bp) was verified by agarose gel electrophoresis and staining with EtBr. Illumina sequencing. Singleend sequencing of barcoded DNA libraries (starting from the forward adaptor and covering the unique nucleosome identifier barcode) was performed by the Lewis Sigler Institute for Integrative Genomics Sequencing Core Facility at Princeton University on an Illumina HiSeq 2500 with read length of 67 bp. Owing to the substantial sequence homogeneity present in samples generated from remodelling experiments, these libraries were diluted with a PhiX control library to enable sequencing. A custom sequencing primer was used to sequence the index read (5′ CAATTGAGCGGCTGCAGCACCGGGATTCTCCAG3′ ). This primer annealed to the 601 sequence and the 8bp index read covered the unique multiplexing barcode. Nucleosome remodelling experiments in the presence of LANA peptides. Remodelling experiments in the presence of LANA and LANA mutant (LRS to AAA) peptides and rate calculations were performed as described in the methods section 'Nucleosome remodelling rate analysis for validation experiments on indi vidual nucleosomes using a restriction enzyme accessibility assay' . LANA peptides were preincubated with unmodified nucleosomes for 10 min on ice before being used in remodelling assays at a final concentration of 10 μ M peptide. Nucleosome remodelling rate analysis for validation experiments on individual nucleosomes using a restriction enzyme accessibility assay. All remodelling experiments validating results obtained from the nucleosome library were per formed on nucleosomes assembled with the 192bp fragment described above (192bp DNA fragment used in followup studies on single nucleosomes). Remodelling assays were performed as described in the section 'Remodelling assays using the nucleosome library' with some modifications. Experiments involving the NURF complex were carried out using nucleosomes at 10 nM and NURF at 50 nM. Experiments involving the ACF complex were performed using nucleosomes at 10 nM and ACF at 2 nM. Experiments involving CHD4 were carried out using nucleosomes at 10 nM and CHD4 at 5 nM. Experiments involving BRG1 were carried out using nucleosomes at 10 nM and BRG1 at 200 nM. All reactions were carried out in the presence of 2 mM ATP. Time points were taken, quenched, and deproteinized as described above (Remodelling assays using the nucleosome library). Samples were directly run on a 5% polyacrylamide gel (0.5× TBE, 200 V, 40 min). Staining was performed with SYBR Safe DNA gel stain and gels were imaged on a Typhoon scanner (GE Healthcare). Densitometry measurements were performed using Image Studio Lite (LICOR). Rates were determined using GraphPad Prism by fitting to a single exponential decay equation (see Extended Data Fig. 8a, c, d, Supplementary Fig. 6 , and section 'Nucleosome remodelling rate analysis for library experiments'). Nucleosome remodelling assays and rate analysis for validation of acidic patch mutant nucleosomes (H2A E61A, D90A, E92) using an electrophoretic mobility shift nucleosome repositioning assay. Octamers and nucleosomes were prepared using a method similar to that previously described 44 with minor modifications. Nucleosomes were assembled by salt gradient dialysis on a 227bp DNA fragment that was prepared using a method similar to that described above (192bp DNA fragment used in followup studies on individual nucleosomes). In this case, primers were designed to amplify the 601 sequence with an 80bp overhang generated from the surrounding vector sequence.
Forward: 5′ CACTATAGGGCGAATTGGAG3′ Reverse -5′ CTGGAGAATCCCGGT3′ DNA fragment generated (bold, 601 sequence): CACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGA ACTAGTGGATCCGATATCGCTGTTCACCGCGTGACAGGATGTATATATCT GACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACG CGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACG ACCAATTGAGCGGCTGCAGCACCGGGATTC TCCAG Fiftymicrolitre remodelling assays were carried out in assay buffer (12 mM HEPES, pH 7.9, 4 mM Tris, pH 7.5, 60 mM KCl, 10 mM MgCl 2 , 10% glycerol, and 0.02% (v/v) IGEPAL CA630) with 30 nM ACF complex and 90 nM nucleosomes. Reactions were preincubated for 10 min at 30 °C before initiation by the addition of nucleosomes. Note that ATP (final concentration equivalent to 2 mM) was not added until approximately 2.5 min before initiation. After initiation, remodelling assays were carried out for 1 h at 30 °C. Sixmicrolitre time points were taken at 1, 2.5, 5, 15, 30, and 60 min and each was quenched by addition of 6 μ l quench buffer (assay buffer with 800 ng/μ l sheared salmon sperm DNA (ThermoFisher Scientific)) and placement on ice. Quenched assay samples were directly run on a 5% TBE gel in 0.5× TBE buffer for 40 min at 200 V. Nucleosomes were visualized by staining with SYBR Gold Nucleic Acid Gel Stain (ThermoFisher Scientific).
Densitometry measurements were performed quantify the movement of nucleosomes away from their initial position using Image Studio Lite (LICOR). Rates were determined using GraphPad Prism by fitting to a single exponential decay equation (Extended Data Fig. 8b ). Processing of sequencing data for chromatin remodelling experiments using the nucleosome library. As previously noted, each remodelling experiment (per enzyme) generated 36 samples (triplicate reactions with and without ATP with six time points collected per reaction). Individual remodelling experiments were processed as follows: 67bp singleend and 8bp index reads were imported into Galaxy (Princeton University installation). Corresponding read pairs (singleend and index) generated from the same fragment were joined to generate single nucleotide sequences that contained both a unique nucleosome identifier barcode and related unique multiplexing barcode. All reads were then split into separate FASTQ files (36 in total) based on their unique multiplexing barcodes using Galaxy's Barcode Splitter tool. Each FASTQ file was exported from Galaxy, and occurrences of each unique nucleosome identifier barcode within each file were counted using a custom R script. This resulted in individual data points com posed of a distinct number of read counts associated with a unique nucleosome identifier barcode and a unique multiplexing barcode.
Also, included in the nucleosome library was a nonnucleosomal DNA fragment identical to BC601 DNA except that it did not contain a PstI site (DNA Standard 1). It was carried with the sample from the initiation of remodelling experiments through Illumina sequencing, and used as an internal reference to normalize relative abundances of DNA between multiplexed samples. After normalization, sample read counts were organized by time point or experimental condition (with or without ATP) and nucleosome type (Supplementary Table 2 ). At this point, nucleosomes 71, 78, and 113 were removed from further analysis as their unique nucleosome identifier barcodes created an additional PstI site with the surrounding nucleotide sequence. Processing of sequencing data for binding experiments using the nucleosome library. Barcode sorting was performed as described in the section 'Processing of sequencing data for chromatin remodelling experiments using the nucleosome library' . To account for variation in abundance of individual library members, raw read counts (Supplementary Table 7) for each nucleosome were first normalized to corresponding values from the input sample. Note that data from a single input sample was used for processing all pulldown experiments. To better visualize how nucleosome modifications or mutations affect binding, these values were then normalized to one of the unmodified nucleosomes in the nucleosome library (nucleosome 42, see Supplementary Table 1) to calculate relative affinity measure ments for all nucleosome library members. Nucleosome remodelling rate analysis for library experiments. For each enzyme, remodelling rate constants per nucleosome were calculated for experimental triplicates in GraphPad Prism. Also, included in the nucleosome library was a nonnucleosomal DNA fragment identical to BC601 DNA (DNA Standard 2). Nucleosome remodelling data were fit to a 2phase exponential decay equation (see below). The first phase (k fast ) was fixed as the rate of cutting of DNA Standard 2 in each experiment (fit to 1phase exponential decay equation). The yintercept was allowed to vary and the plateau was set to zero. Fitting to this model allowed the second phase (k slow ) to be determined as the rate of nucleosome remodelling (this parameter was left unconstrained) (see Supplementary Fig. 6 and below) . Additionally, to estimate the minimum rate of remodelling capable of being deter mined by our analysis methods, we averaged the bottom 1% of rates that had 95% confidence interval nonoverlapping with zero and calculated the associated error. Any values below this threshold were set equal to it. This included cases where k slow was extremely slow (the curve very flat) and determined to be slightly negative. The remodelling rates of unmodified nucleosomes in the library were then averaged and the associated error was calculated. Log 2 (foldchange) values relative to the unmodified nucleosome rate average and associated errors were then computed for each nucleosome in the library. Singular value decomposition of the nucleosome library data was calculated for PCA with the Python module matplotlib.mlab (v. 1.4.3) .
Fitting the remodelling kinetic data to a 2phase decay was necessary to account for the presence of free BC601 DNA for some members in the libraryin particular nucleosomes containing polyacetylated H3 and H4 ( Supplementary  Fig. 6b ). Use of a 1phase exponential decay led to an overestimation of the rate constants (and a poorer fit) for several library members, owing to the contribution of the free DNA that is rapidly cut by the PstI restriction enzyme, irrespective of remodelling activity ( Supplementary Fig. 6a, c) . Fitting the data to the 2phase exponential led to a better fit for those library members. The first phase accounts for the free DNA, whereas the slower second phase reports on the remodelling rate of the nucleosome. Note, the vast majority of library members had minimal free BC601 DNA and could be analysed equally well using 1 or 2phase decays ( Supplementary Fig. 6e, f) . For consistency, we used the 2phase decay fit throughout. Contributions of free DNA to rate measurements were generally thought to be dependent not on systematic irreproducibility in the nucleosome assembly procedures used in this study, but typically on the relative affinities of certain modified histone octamers for nucleosomal DNA as observed by gel electrophoresis. For example, polyacetylated nucleosomes tended to show such behaviour ( Supplementary Fig. 6b ). We therefore propose that the amount of free DNA in a nucleosome preparation must be carefully considered when fitting nucle osome remodelling data generated by a restriction enzyme accessibility assay to a 1phase exponential decay equation. In the case, where an internal standard to measure the rate of cutting of nonnucleosomal DNA is present (DNA standard 2 in our highthroughput nucleosome remodelling assay), data may be better modelled by a 2phase exponential decay equation to aid in accounting for the presence of any free DNA. This proves advantageous in situations where large numbers of nucleosomes must be prepared and precious material is limited or if nucleosome assembly reactions prove difficult to optimize. Code availability. A custom R script was used to count individual DNA barcodes in the processing of sequencing data. Requests to access this code may be sent to T.W.M. (muir@princeton.edu). Data availability. The authors declare that all data supporting the findings of this study are available from the authors and are included within the paper, Extended Data, and its Supplementary Information files. 
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